1 Biologic Injectors Market Overview 1.1 Product Overview and Scope of Biologic Injectors 1.2 Biologic Injectors Segment by Type 1.2.1 Global Biologic Injectors Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Disposable Biologic Injectors 1.2.3 Reusable Biologic Injectors 1.3 Biologic Injectors Segment by Application 1.3.1 Global Biologic Injectors Sales Comparison by Application: (2022-2028) 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Ambulatory Surgical Centers 1.3.5 Others 1.4 Global Biologic Injectors Market Size Estimates and Forecasts 1.4.1 Global Biologic Injectors Revenue 2017-2028 1.4.2 Global Biologic Injectors Sales 2017-2028 1.4.3 Biologic Injectors Market Size by Region: 2017 Versus 2021 Versus 2028 2 Biologic Injectors Market Competition by Manufacturers 2.1 Global Biologic Injectors Sales Market Share by Manufacturers (2017-2022) 2.2 Global Biologic Injectors Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Biologic Injectors Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Biologic Injectors Manufacturing Sites, Area Served, Product Type 2.5 Biologic Injectors Market Competitive Situation and Trends 2.5.1 Biologic Injectors Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Biologic Injectors Players Market Share by Revenue 2.5.3 Global Biologic Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Biologic Injectors Retrospective Market Scenario by Region 3.1 Global Biologic Injectors Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Biologic Injectors Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Biologic Injectors Market Facts & Figures by Country 3.3.1 North America Biologic Injectors Sales by Country 3.3.2 North America Biologic Injectors Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Biologic Injectors Market Facts & Figures by Country 3.4.1 Europe Biologic Injectors Sales by Country 3.4.2 Europe Biologic Injectors Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Biologic Injectors Market Facts & Figures by Region 3.5.1 Asia Pacific Biologic Injectors Sales by Region 3.5.2 Asia Pacific Biologic Injectors Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Biologic Injectors Market Facts & Figures by Country 3.6.1 Latin America Biologic Injectors Sales by Country 3.6.2 Latin America Biologic Injectors Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Biologic Injectors Market Facts & Figures by Country 3.7.1 Middle East and Africa Biologic Injectors Sales by Country 3.7.2 Middle East and Africa Biologic Injectors Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Biologic Injectors Historic Market Analysis by Type 4.1 Global Biologic Injectors Sales Market Share by Type (2017-2022) 4.2 Global Biologic Injectors Revenue Market Share by Type (2017-2022) 4.3 Global Biologic Injectors Price by Type (2017-2022) 5 Global Biologic Injectors Historic Market Analysis by Application 5.1 Global Biologic Injectors Sales Market Share by Application (2017-2022) 5.2 Global Biologic Injectors Revenue Market Share by Application (2017-2022) 5.3 Global Biologic Injectors Price by Application (2017-2022) 6 Key Companies Profiled 6.1 BD 6.1.1 BD Corporation Information 6.1.2 BD Description and Business Overview 6.1.3 BD Biologic Injectors Sales, Revenue and Gross Margin (2017-2022) 6.1.4 BD Biologic Injectors Product Portfolio 6.1.5 BD Recent Developments/Updates 6.2 Johnson & Johnson 6.2.1 Johnson & Johnson Corporation Information 6.2.2 Johnson & Johnson Description and Business Overview 6.2.3 Johnson & Johnson Biologic Injectors Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Johnson & Johnson Biologic Injectors Product Portfolio 6.2.5 Johnson & Johnson Recent Developments/Updates 6.3 Roche 6.3.1 Roche Corporation Information 6.3.2 Roche Description and Business Overview 6.3.3 Roche Biologic Injectors Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Roche Biologic Injectors Product Portfolio 6.3.5 Roche Recent Developments/Updates 6.4 Schott 6.4.1 Schott Corporation Information 6.4.2 Schott Description and Business Overview 6.4.3 Schott Biologic Injectors Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Schott Biologic Injectors Product Portfolio 6.4.5 Schott Recent Developments/Updates 6.5 Bayer 6.5.1 Bayer Corporation Information 6.5.2 Bayer Description and Business Overview 6.5.3 Bayer Biologic Injectors Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Bayer Biologic Injectors Product Portfolio 6.5.5 Bayer Recent Developments/Updates 6.6 Nipro 6.6.1 Nipro Corporation Information 6.6.2 Nipro Description and Business Overview 6.6.3 Nipro Biologic Injectors Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Nipro Biologic Injectors Product Portfolio 6.6.5 Nipro Recent Developments/Updates 6.7 Ompi 6.6.1 Ompi Corporation Information 6.6.2 Ompi Description and Business Overview 6.6.3 Ompi Biologic Injectors Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Ompi Biologic Injectors Product Portfolio 6.7.5 Ompi Recent Developments/Updates 6.8 Novartis 6.8.1 Novartis Corporation Information 6.8.2 Novartis Description and Business Overview 6.8.3 Novartis Biologic Injectors Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Novartis Biologic Injectors Product Portfolio 6.8.5 Novartis Recent Developments/Updates 7 Biologic Injectors Manufacturing Cost Analysis 7.1 Biologic Injectors Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Biologic Injectors 7.4 Biologic Injectors Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Biologic Injectors Distributors List 8.3 Biologic Injectors Customers 9 Biologic Injectors Market Dynamics 9.1 Biologic Injectors Industry Trends 9.2 Biologic Injectors Market Drivers 9.3 Biologic Injectors Market Challenges 9.4 Biologic Injectors Market Restraints 10 Global Market Forecast 10.1 Biologic Injectors Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Biologic Injectors by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Biologic Injectors by Type (2023-2028) 10.2 Biologic Injectors Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Biologic Injectors by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Biologic Injectors by Application (2023-2028) 10.3 Biologic Injectors Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Biologic Injectors by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Biologic Injectors by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Biologic Injectors Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Biologic Injectors Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Biologic Injectors Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Biologic Injectors Market Competitive Situation by Manufacturers in 2021 Table 5. Global Biologic Injectors Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Biologic Injectors Sales Market Share by Manufacturers (2017-2022) Table 7. Global Biologic Injectors Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Biologic Injectors Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Biologic Injectors Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Biologic Injectors Manufacturing Sites and Area Served Table 11. Manufacturers Biologic Injectors Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Biologic Injectors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Injectors as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Biologic Injectors Sales by Region (2017-2022) & (K Units) Table 16. Global Biologic Injectors Sales Market Share by Region (2017-2022) Table 17. Global Biologic Injectors Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Biologic Injectors Revenue Market Share by Region (2017-2022) Table 19. North America Biologic Injectors Sales by Country (2017-2022) & (K Units) Table 20. North America Biologic Injectors Sales Market Share by Country (2017-2022) Table 21. North America Biologic Injectors Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Biologic Injectors Revenue Market Share by Country (2017-2022) Table 23. Europe Biologic Injectors Sales by Country (2017-2022) & (K Units) Table 24. Europe Biologic Injectors Sales Market Share by Country (2017-2022) Table 25. Europe Biologic Injectors Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Biologic Injectors Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Biologic Injectors Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Biologic Injectors Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Biologic Injectors Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Biologic Injectors Revenue Market Share by Region (2017-2022) Table 31. Latin America Biologic Injectors Sales by Country (2017-2022) & (K Units) Table 32. Latin America Biologic Injectors Sales Market Share by Country (2017-2022) Table 33. Latin America Biologic Injectors Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Biologic Injectors Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Biologic Injectors Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Biologic Injectors Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Biologic Injectors Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Biologic Injectors Revenue Market Share by Country (2017-2022) Table 39. Global Biologic Injectors Sales by Type (2017-2022) & (K Units) Table 40. Global Biologic Injectors Sales Market Share by Type (2017-2022) Table 41. Global Biologic Injectors Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Biologic Injectors Revenue Share by Type (2017-2022) Table 43. Global Biologic Injectors Price by Type (2017-2022) & (USD/Unit) Table 44. Global Biologic Injectors Sales (K Units) by Application (2017-2022) Table 45. Global Biologic Injectors Sales Market Share by Application (2017-2022) Table 46. Global Biologic Injectors Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Biologic Injectors Revenue Share by Application (2017-2022) Table 48. Global Biologic Injectors Price by Application (2017-2022) & (USD/Unit) Table 49. BD Corporation Information Table 50. BD Description and Business Overview Table 51. BD Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 52. BD Biologic Injectors Product Table 53. BD Recent Developments/Updates Table 54. Johnson & Johnson Corporation Information Table 55. Johnson & Johnson Description and Business Overview Table 56. Johnson & Johnson Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 57. Johnson & Johnson Biologic Injectors Product Table 58. Johnson & Johnson Recent Developments/Updates Table 59. Roche Corporation Information Table 60. Roche Description and Business Overview Table 61. Roche Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 62. Roche Biologic Injectors Product Table 63. Roche Recent Developments/Updates Table 64. Schott Corporation Information Table 65. Schott Description and Business Overview Table 66. Schott Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 67. Schott Biologic Injectors Product Table 68. Schott Recent Developments/Updates Table 69. Bayer Corporation Information Table 70. Bayer Description and Business Overview Table 71. Bayer Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 72. Bayer Biologic Injectors Product Table 73. Bayer Recent Developments/Updates Table 74. Nipro Corporation Information Table 75. Nipro Description and Business Overview Table 76. Nipro Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Nipro Biologic Injectors Product Table 78. Nipro Recent Developments/Updates Table 79. Ompi Corporation Information Table 80. Ompi Description and Business Overview Table 81. Ompi Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Ompi Biologic Injectors Product Table 83. Ompi Recent Developments/Updates Table 84. Novartis Corporation Information Table 85. Novartis Description and Business Overview Table 86. Novartis Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. Novartis Biologic Injectors Product Table 88. Novartis Recent Developments/Updates Table 89. Production Base and Market Concentration Rate of Raw Material Table 90. Key Suppliers of Raw Materials Table 91. Biologic Injectors Distributors List Table 92. Biologic Injectors Customers List Table 93. Biologic Injectors Market Trends Table 94. Biologic Injectors Market Drivers Table 95. Biologic Injectors Market Challenges Table 96. Biologic Injectors Market Restraints Table 97. Global Biologic Injectors Sales Forecast by Type (2023-2028) & (K Units) Table 98. Global Biologic Injectors Sales Market Share Forecast by Type (2023-2028) Table 99. Global Biologic Injectors Revenue Forecast by Type (2023-2028) & (US$ Million) Table 100. Global Biologic Injectors Revenue Market Share Forecast by Type (2023-2028) Table 101. Global Biologic Injectors Sales Forecast by Application (2023-2028) & (K Units) Table 102. Global Biologic Injectors Sales Market Share Forecast by Application (2023-2028) Table 103. Global Biologic Injectors Revenue Forecast by Application (2023-2028) & (US$ Million) Table 104. Global Biologic Injectors Revenue Market Share Forecast by Application (2023-2028) Table 105. Global Biologic Injectors Sales Forecast by Region (2023-2028) & (K Units) Table 106. Global Biologic Injectors Sales Market Share Forecast by Region (2023-2028) Table 107. Global Biologic Injectors Revenue Forecast by Region (2023-2028) & (US$ Million) Table 108. Global Biologic Injectors Revenue Market Share Forecast by Region (2023-2028) Table 109. Research Programs/Design for This Report Table 110. Key Data Information from Secondary Sources Table 111. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Biologic Injectors Figure 2. Global Biologic Injectors Market Share by Type in 2021 & 2028 Figure 3. Disposable Biologic Injectors Product Picture Figure 4. Reusable Biologic Injectors Product Picture Figure 5. Global Biologic Injectors Market Share by Application in 2021 & 2028 Figure 6. Hospitals Figure 7. Clinics Figure 8. Ambulatory Surgical Centers Figure 9. Others Figure 10. Global Biologic Injectors Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Biologic Injectors Market Size (2017-2028) & (US$ Million) Figure 12. Global Biologic Injectors Sales (2017-2028) & (K Units) Figure 13. Biologic Injectors Sales Share by Manufacturers in 2021 Figure 14. Global Biologic Injectors Revenue Share by Manufacturers in 2021 Figure 15. The Global 5 and 10 Largest Biologic Injectors Players: Market Share by Revenue in 2021 Figure 16. Biologic Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 17. Global Biologic Injectors Sales Market Share by Region (2017-2022) Figure 18. Global Biologic Injectors Sales Market Share by Region in 2021 Figure 19. Global Biologic Injectors Revenue Market Share by Region (2017-2022) Figure 20. Global Biologic Injectors Revenue Market Share by Region in 2021 Figure 21. U.S. Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Canada Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. Germany Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. France Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. U.K. Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Italy Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Russia Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. China Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Japan Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. South Korea Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. India Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Australia Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Taiwan Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Indonesia Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Thailand Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Malaysia Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Philippines Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Vietnam Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Mexico Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Brazil Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Argentina Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Turkey Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Saudi Arabia Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. UAE Biologic Injectors Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Sales Market Share of Biologic Injectors by Type (2017-2022) Figure 46. Manufacturing Cost Structure of Biologic Injectors Figure 47. Manufacturing Process Analysis of Biologic Injectors Figure 48. Biologic Injectors Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

BD Johnson & Johnson Roche Schott Bayer Nipro Ompi Novartis